SC 13G Filing

Company

C4 Therapeutics, Inc.

Filed

October 16, 2020

Accession Number

0000929638-20-001002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →